Impact BioMedical Inc.
IBO
$0.78
$0.3268.47%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 457.05% | 89.76% | -1,032.36% | 95.33% | -737.99% |
| Total Depreciation and Amortization | -66.59% | 42,700.00% | 100.00% | -50.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -298.60% | 1.42% | 1.81% | -0.72% |
| Total Other Non-Cash Items | -1,235.55% | -96.06% | 4,490.72% | -98.89% | 586.93% |
| Change in Net Operating Assets | 1,188.10% | 600.00% | -45.45% | 102.67% | -196.40% |
| Cash from Operations | 116.15% | 11.67% | -1.76% | 30.83% | 1.50% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -- | -100.00% | -- | -100.00% |
| Cash from Investing | 0.00% | -- | -100.00% | -- | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | 628.33% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -91.35% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.53% | 11.82% | -1.91% | -1.79% | -125.09% |